| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/12/2012 | CN102665726A 抗癌剂 Anticancer agent |
| 09/12/2012 | CN102665724A Composition containing protopanaxatriol and protopanaxadiol |
| 09/12/2012 | CN102665711A Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents |
| 09/12/2012 | CN102665706A Antioxidant composition |
| 09/12/2012 | CN102665700A Methods and compositions for treating solid tumors and other malignancies |
| 09/12/2012 | CN102665690A Sustained-release formulation |
| 09/12/2012 | CN102665689A Oxaliplatin nanoparticles and method for preparing same |
| 09/12/2012 | CN102660579A HBx and human IL-12 double-gene recombinant vector and liver caner-resistant vaccine |
| 09/12/2012 | CN102660567A Method for constructing pGM (granulocyte-macrophage) CSF (colony-stimulating factor)-IRES (internal ribosome entry site)-Rae1-IL (interleukin)21 vector |
| 09/12/2012 | CN102660543A Method, product and application of chemical modification of siRNA sequence using isonucleoside |
| 09/12/2012 | CN102660542A Cervical carcinoma diagnosis and treatment method based on micro RNA |
| 09/12/2012 | CN102660499A Placental hematopoietic stem cell and preparation method thereof and placental hematopoietic stem cell injection |
| 09/12/2012 | CN102660419A Multifunctional health-care wine |
| 09/12/2012 | CN102659946A Anti-alpha v beta 6 antibodies |
| 09/12/2012 | CN102659945A Anti-C5aR antibodies and uses thereof |
| 09/12/2012 | CN102659944A IL-18 binding proteins |
| 09/12/2012 | CN102659921A HLA-A*0201 restrictive CTL epitope of neuritin protein, and application of HLA-A*0201 restrictive CTL epitope |
| 09/12/2012 | CN102659895A Steroid alkaloid hydrochloride, its preparation method and application |
| 09/12/2012 | CN102659889A Preparation of 23, 24-dihydro-epi-iso-cucurbitacin D and use in antitumor drug thereof |
| 09/12/2012 | CN102659871A Method for extracting and refining anthocyanin in black rice |
| 09/12/2012 | CN102659849A Platinum (II) complex with antitumor activity and preparation method thereof |
| 09/12/2012 | CN102659841A Polyphenol phosphamide derivative, and preparation method and application thereof |
| 09/12/2012 | CN102659840A Imidazole diphosphonie acid compound and pharmaceutically-acceptable salt and medicinal application thereof |
| 09/12/2012 | CN102659837A Solanesol phosphamide derivatives and their preparation method and use |
| 09/12/2012 | CN102659803A Sesterterpene compound and preparation method and application thereof |
| 09/12/2012 | CN102659802A Preparation method of coumarin lignan compounds and application of coumarin lignan compounds in resisting marine fouling |
| 09/12/2012 | CN102659800A Hypoxia-activated antitumor compounds and application thereof |
| 09/12/2012 | CN102659793A Phthalocyanine silicon modified by amino ethyl groups and phenoxy groups as well as preparation method and application thereof |
| 09/12/2012 | CN102659787A Fluoro polyhydroxy pyrrole pyrrolizidine, and preparation method and application thereof |
| 09/12/2012 | CN102659785A 2-amino-6-aminomethylpurine compound and preparation method and application thereof |
| 09/12/2012 | CN102659777A Antitumor medicament |
| 09/12/2012 | CN102659765A Pyrimidine and triazine compound preparation method and application |
| 09/12/2012 | CN102659764A Tyrosine kinase inreversible inhibitor, its preparation method and application |
| 09/12/2012 | CN102659746A Ailanthus flower extract as well as preparation method and application of active ingredients brevifolin of ailanthus flower extract |
| 09/12/2012 | CN102659735A Quercetin-3-O-acyl ester and preparation method thereof |
| 09/12/2012 | CN102659722A Amorphous cabazitaxel and preparation method thereof |
| 09/12/2012 | CN102659705A Synthetic method of 3,4-disubstituted isoxazole compound |
| 09/12/2012 | CN102659703A New compound N<1>,N<4>-di(3,4-dimethoxyphenyl)-3,6-dimethyl-1,2,4,5-tetrazine-1,4-diformamide, preparation thereof and application thereof |
| 09/12/2012 | CN102659692A Double-linked Erlotinib and preparation method thereof |
| 09/12/2012 | CN102659689A 4-substituted-2-butoxy-5-fluoropyrimidine compounds, and preparation method and application thereof |
| 09/12/2012 | CN102659661A Synthetic method and application of shikonin derivative |
| 09/12/2012 | CN102659630A Hydroxamic acid compound and preparation method as well as application thereof |
| 09/12/2012 | CN102659617A L-tyrosine derivative, medicine compound and application thereof |
| 09/12/2012 | CN102659593A Shikonin benzene oxygen carboxylic acid ester derivative and synthesizing method and application thereof |
| 09/12/2012 | CN102657880A Quaternized chitosan/siRNA (small interfering Ribonucleic Acid) composite particles and preparation method thereof |
| 09/12/2012 | CN102657879A Application of yeast expressing product of gentiana straminea beta-amyrin synthetase gene GsAS in pharmacy |
| 09/12/2012 | CN102657878A Application of small activating RNA (Ribonucleic Acid) of INTS6 (Homo Sapiens Integrator Complex Subunit 6) gene to preparation of prostate cancer fighting medicament |
| 09/12/2012 | CN102657873A Vesicles consisting of amphiphilic polymer and application of vesicles |
| 09/12/2012 | CN102657872A Multifunctional graphene oxide/ polyamide-amine (PAMAM)/ diethylene triamine pentaacetic-gadolinium (DTPA-Gd)/ prostate stem cell antigen (PSCA) antibody material and preparation method and application thereof |
| 09/12/2012 | CN102657867A Transcriptional regulator combination |
| 09/12/2012 | CN102657866A Cancer prevention and fighting capsules |
| 09/12/2012 | CN102657854A Multi-epitope vaccine YL66 and application of preparing vaccine for treating tumour |
| 09/12/2012 | CN102657853A Preparation and application of tumor specific killer cells serving as source of initial thymus (T) cells |
| 09/12/2012 | CN102657852A Medical composition of recombinant Wautersiella asparaginase and preparation method and application thereof |
| 09/12/2012 | CN102657849A Application of toad maggot protein in medicine used for treating cervical cancer |
| 09/12/2012 | CN102657848A Application of toad maggot protein in medicine used for treating colon cancer |
| 09/12/2012 | CN102657847A Application of toad maggot protein in medicine used for treating rectal cancer |
| 09/12/2012 | CN102657846A Compound traditional Chinese medicine active ingredient preparation used for treating leukemia and production method thereof |
| 09/12/2012 | CN102657840A Stasis-removing and inflammation-diminishing traditional Chinese medicine composition, stasis-removing and inflammation-diminishing pills, stasis-removing and inflammation-diminishing plaster and preparation method thereof |
| 09/12/2012 | CN102657823A Traditional Chinese medicine composition with anticancer effect and preparation method and detection method thereof |
| 09/12/2012 | CN102657815A Chinese patent medicine orally-taken pill for treating malignant tumors |
| 09/12/2012 | CN102657718A Preparation method for high content fructus crataegi flavone |
| 09/12/2012 | CN102657693A SH2-containing tyrosine phosphatase 1(SHP-1) inhibitor and preparation thereof |
| 09/12/2012 | CN102657674A Application of Trichoderma pseudokoningii extracellular polysaccharides having anticancer activities |
| 09/12/2012 | CN102657669A Application of sea cucumber saponin compound Frondoside A6 in preparation of anti-tumor medicines |
| 09/12/2012 | CN102657667A Novel inhibitory action of stilbene glycoside on generation of tumor vessels and application of stilbene glycoside |
| 09/12/2012 | CN102657660A Application of total triterpenes in preparing drugs inhibiting angiogenesis |
| 09/12/2012 | CN102657656A Composition and methods for modulating a kinase cascade |
| 09/12/2012 | CN102657653A Agent for selectively killing tumor stem cells and use thereof |
| 09/12/2012 | CN102657624A High optical purity trans-dextro oxaliplatin lyophilized powder injection and preparation method thereof |
| 09/12/2012 | CN102657599A Method for preparing bioactive injectable hydrogel materials for oncotherapy |
| 09/12/2012 | CN102657597A Biodegradable super-molecular hydrogel loaded with antitumor medicament and preparation method thereof |
| 09/12/2012 | CN102241674B Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester |
| 09/12/2012 | CN102232957B Use of 3-acetoxyl-8, 24-lanostadiene-21-acid in preparing medicines for preventing or treating liver cancer or breast cancer |
| 09/12/2012 | CN102219860B FGFR-Fc fusion protein and applications thereof |
| 09/12/2012 | CN102219859B Fusion protein for antagonizing angiogenesis inducible factor and application thereof |
| 09/12/2012 | CN102178958B MBD2-mTEM fused DNA vaccine and preparation method and application thereof |
| 09/12/2012 | CN102178653B Aclacinomycin nanometer grain and preparation method thereof |
| 09/12/2012 | CN102166187B Recombinant human endostatin sustained-release injection oil preparation and preparation process thereof |
| 09/12/2012 | CN102058580B New application of 15-oxospiramilactone for inhibition of Wnt signal path |
| 09/12/2012 | CN101987197B Method and reagent for inhibiting invasiveness of cancer cells |
| 09/12/2012 | CN101961494B Star polymer nano-medicament carrier preparation used for intracellular medicament delivery and preparation method thereof |
| 09/12/2012 | CN101829051B 1'-acetoxychavicol acetate injection |
| 09/12/2012 | CN101781347B Polymorphic substances of decitabine and medical compositions |
| 09/12/2012 | CN101760446B Method for preparing monocyte type stem cell and application |
| 09/12/2012 | CN101735179B Method for preparing docetaxel, intermediate thereof and preparation method |
| 09/12/2012 | CN101715956B Multifunctional health juice with stable effective ingredients and processing method thereof |
| 09/12/2012 | CN101687863B Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer |
| 09/12/2012 | CN101675961B A medicinal preparation for treating breast cancer and preparation method thereof |
| 09/12/2012 | CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase |
| 09/12/2012 | CN101569627B Folic acid acceptor mediated molecular targeted photosensitizer and preparation method thereof |
| 09/12/2012 | CN101506221B Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors |
| 09/12/2012 | CN101360761B Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use |
| 09/12/2012 | CN101244039B Novel method for preparing indissoluble medicaments liposome preparations |
| 09/12/2012 | CN101108826B Method for normal-temperature high-pressure aconine extracting and formulated product thereof |
| 09/12/2012 | CN101007851B Chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 09/11/2012 | US8263765 Pyrrolotriazine kinase inhibitors |
| 09/11/2012 | US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide |
| 09/11/2012 | US8263614 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 09/11/2012 | US8263594 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |